Dunne MR - Search Results

1

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines.

Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Donlon NE, et al. Among authors: dunne mr. Cancers (Basel). 2020 Nov 13;12(11):3356. doi: 10.3390/cancers12113356. Cancers (Basel). 2020. PMID: 33202734 Free PMC article.

2

Obesity-associated cancer: an immunological perspective.

Conroy MJ, Dunne MR, Donohoe CL, Reynolds JV. Conroy MJ, et al. Among authors: dunne mr. Proc Nutr Soc. 2016 May;75(2):125-38. doi: 10.1017/S0029665115004176. Epub 2015 Nov 16. Proc Nutr Soc. 2016. PMID: 26567898 Review.

3

Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study.

Guinan EM, Doyle SL, O'Neill L, Dunne MR, Foley EK, O'Sullivan J, Reynolds JV, Hussey J. Guinan EM, et al. Among authors: dunne mr. Support Care Cancer. 2017 Mar;25(3):749-756. doi: 10.1007/s00520-016-3455-0. Epub 2016 Nov 3. Support Care Cancer. 2017. PMID: 27807666 Clinical Trial.

4

HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.

Dunne MR, Michielsen AJ, O'Sullivan KE, Cathcart MC, Feighery R, Doyle B, Watson JA, O'Farrell NJ, Ravi N, Kay E, Reynolds JV, Ryan EJ, O'Sullivan J. Dunne MR, et al. Cancer Immunol Immunother. 2017 Jul;66(7):841-850. doi: 10.1007/s00262-017-1983-1. Epub 2017 Mar 18. Cancer Immunol Immunother. 2017. PMID: 28315927 Free PMC article.

5

Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma.

Galvin KC, Conroy MJ, Doyle SL, Dunne MR, Fahey R, Foley E, O'Sullivan KE, Doherty DG, Geoghegan JG, Ravi N, O'Farrelly C, Reynolds JV, Lysaght J. Galvin KC, et al. Among authors: dunne mr. Cancer Lett. 2018 Apr 1;418:230-238. doi: 10.1016/j.canlet.2018.01.039. Epub 2018 Jan 12. Cancer Lett. 2018. PMID: 29339209

6

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma.

Buckley AM, Lynam-Lennon N, Kennedy SA, Dunne MR, Aird JJ, Foley EK, Clarke N, Ravi N, O'Toole D, Reynolds JV, Kennedy BN, O'Sullivan J. Buckley AM, et al. Among authors: dunne mr. Oncotarget. 2018 Sep 14;9(72):33634-33647. doi: 10.18632/oncotarget.25950. eCollection 2018 Sep 14. Oncotarget. 2018. PMID: 30263091 Free PMC article.

7

Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma.

Buckley AM, Dunne MR, Lynam-Lennon N, Kennedy SA, Cannon A, Reynolds AL, Maher SG, Reynolds JV, Kennedy BN, O'Sullivan J. Buckley AM, et al. Among authors: dunne mr. Cancer Lett. 2019 Apr 10;447:115-129. doi: 10.1016/j.canlet.2019.01.009. Epub 2019 Jan 19. Cancer Lett. 2019. PMID: 30664962

8

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells.

Buckley AM, Bibby BA, Dunne MR, Kennedy SA, Davern MB, Kennedy BN, Maher SG, O'Sullivan J. Buckley AM, et al. Among authors: dunne mr. Pharmaceuticals (Basel). 2019 Feb 20;12(1):33. doi: 10.3390/ph12010033. Pharmaceuticals (Basel). 2019. PMID: 30791601 Free PMC article.

9

Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.

Melo AM, O'Brien AM, Phelan JJ, Kennedy SA, Wood NAW, Veerapen N, Besra GS, Clarke NE, Foley EK, Ravi A, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, Conroy MJ, Hogan AE, O'Sullivan J, Dunne MR. Melo AM, et al. Among authors: dunne mr. Front Immunol. 2019 Jul 10;10:1580. doi: 10.3389/fimmu.2019.01580. eCollection 2019. Front Immunol. 2019. PMID: 31354725 Free PMC article.

10

An investigation into the modulation of T cell phenotypes by amitriptyline and nortriptyline.

Royds J, Conroy MJ, Dunne MR, McCrory C, Lysaght J. Royds J, et al. Among authors: dunne mr. Eur Neuropsychopharmacol. 2020 Feb;31:131-144. doi: 10.1016/j.euroneuro.2019.12.106. Epub 2019 Dec 24. Eur Neuropsychopharmacol. 2020. PMID: 31882254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page